Age: 60.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Body temperature, Dyspnoea, Headache, Pustule, Pyrexia
Clinical narrative: she had a fever of 101F (her normal body temp is 96.8F); rash on her forehead; little pustules; headache; little trouble breathing; This is a spontaneous report received from a Pfizer sponsored program via a contactable consumer (patient) reported for herself. A 60-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown, Expiry date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was 60 years) as 1ST DOSE, SINGLE for COVID-19 immunisation. Medical history included she had an anaphylactic reaction twice in her life, once to macadamia nuts, and once to "an allergy shot with dust stuff in it". She had a complicated allergy history. Also reported allergies to corn and Benadryl and allergic to an ingredient in benadryl, originally reported as "polypropylene glycol", but later corrected to "polyethylene glycol". The patient was allergic to corn and poly-something in BENADRYL so she couldn't take it anymore. Co-suspect medication included diphenhydramine hydrochloride (BENADRYL). She stated that after the first dose, she had fever of 101F (her normal body temp is 96.8F), a rash on her forehead, and a headache, and noted that on the second day she 'had a little trouble breathing' but said it might be from seasonal allergies. Pretty normal reactions- her normal body temperature was 96.8F had a fever of 101F that's one of the regular side effects and a little bit of a problem breathing- on the second day. Rash on forehead right away, headache too. kept a cold compress and kept switching it every couple of minutes b/c of the fever little pustules. When she put the cloth on regularly it soaked her skin. Rash went away after she had 2 anaphylactic rxn - macadamia nut & allergen shot that had dust stuff in it. She treated the fever and forehead rash with cool compresses and kept switching it every couple of minutes, putting the cloth on regularly it soaked in skin and noted that the rash had what appeared to be 'little pustules" and thought the rash may have been caused by the fever because they resolved at the same time. She had a side effect after the first dose of the vaccine. She asked whether she could receive the second dose and whether she should get the second dose. The nurse that gave her husband his shot said that the reactions to the second dose were more severe. She received the response stating that provided contraindications and discussed potential signs and symptoms of severe allergic reaction as listed in 'CONS-what are the risks of the vaccine (v5.0)' and when they would expect them to occur. Confirmed that fever was commonly reported and that common AEs were more frequently reported after dose 2 in clinical trials (Tables 1-4).  Referred caller to her HCP or vaccination site for additional guidance and monitoring. Confirmed that polyethylene glycol is an ingredient in the Pfizer Covid19 vaccine. She should not get the Pfizer-BioNTech COVID-19 Vaccine if she had a severe allergic reaction after a previous dose of the vaccine or if she had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. They referred her to speak to her healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Her healthcare provider knew her health situation and had access to information that can better help inform that decision. The caller was unsure if she should take 2nd dose of COVID vaccine. Bendadryl no longer Pfizer but unclear when she developed allergy to it. The outcome of events she had a fever of 101F (her normal body temp is 96.8F), rash and little pustules was recovered on an unknown date. The outcome of the events headache and little trouble breathing was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Follow-up (16Apr2021): New information received from a Pfizer-sponsored program via a contactable consumer (patient) reported for herself included: Added Benadryl as co-suspect medication.